Table of Contents

November 1998; 21 (11)

- D J Pettitt
Gestational diabetes mellitus: who to test. How to test.
Diabetes Care November 1998 21:1789; doi:10.2337/diacare.21.11.1789
- Full Text (PDF)
Select this article
- J T Dubuisson,
- L E Wagenknecht,
- R B D'Agostino, Jr,
- S M Haffner,
- M Rewers,
- M F Saad,
- A Laws,
- and D M Herrington
Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.
Diabetes Care November 1998 21:1790-1796; doi:10.2337/diacare.21.11.1790
- Abstract
- Full Text (PDF)
Select this article
- A Elhendy,
- R T van Domburg,
- D Poldermans,
- J J Bax,
- P R Nierop,
- M L Geleijnse,
- and J R Roelandt
Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test.
Diabetes Care November 1998 21:1797-1802; doi:10.2337/diacare.21.11.1797
- Abstract
- Full Text (PDF)
Select this article
- R G Moses,
- J Moses,
- and W S Davis
Gestational diabetes: do lean young caucasian women need to be tested?
Diabetes Care November 1998 21:1803-1806; doi:10.2337/diacare.21.11.1803
- Abstract
- Full Text (PDF)
Select this article
- R G Moses,
- M Moses,
- K G Russell,
- and G M Schier
The 75-g glucose tolerance test in pregnancy: a reference range determined on a low-risk population and related to selected pregnancy outcomes.
Diabetes Care November 1998 21:1807-1811; doi:10.2337/diacare.21.11.1807
- Abstract
- Full Text (PDF)
Select this article
- L E Wagenknecht,
- R B D'Agostino, Jr,
- S M Haffner,
- P J Savage,
- and M Rewers
Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study.
Diabetes Care November 1998 21:1812-1818; doi:10.2337/diacare.21.11.1812
- Abstract
- Full Text (PDF)
Select this article
- V Mohan,
- R Deepa,
- S P Haranath,
- G Premalatha,
- M Rema,
- N G Sastry,
- and E A Enas
Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India.
Diabetes Care November 1998 21:1819-1823; doi:10.2337/diacare.21.11.1819
- Abstract
- Full Text (PDF)
Select this article
- I M Libman,
- M Pietropaolo,
- M Trucco,
- J S Dorman,
- R E LaPorte,
- and D Becker
Islet cell autoimmunity in white and black children and adolescents with IDDM.
Diabetes Care November 1998 21:1824-1827; doi:10.2337/diacare.21.11.1824
- Abstract
- Full Text (PDF)
Select this article
- H E Resnick,
- P Valsania,
- J B Halter,
- and X Lin
Differential effects of BMI on diabetes risk among black and white Americans.
Diabetes Care November 1998 21:1828-1835; doi:10.2337/diacare.21.11.1828
- Abstract
- Full Text (PDF)
Select this article
- I S Okosun,
- R S Cooper,
- C N Rotimi,
- B Osotimehin,
- and T Forrester
Association of waist circumference with risk of hypertension and type 2 diabetes in Nigerians, Jamaicans, and African-Americans.
Diabetes Care November 1998 21:1836-1842; doi:10.2337/diacare.21.11.1836
- Abstract
- Full Text (PDF)
Select this article
- C C Cronin,
- J M McPartlin,
- D G Barry,
- J B Ferriss,
- J M Scott,
- and D G Weir
Plasma homocysteine concentrations in patients with type 1 diabetes.
Diabetes Care November 1998 21:1843-1847; doi:10.2337/diacare.21.11.1843
- Abstract
- Full Text (PDF)
Select this article
- H Taniwaki,
- Y Nishizawa,
- T Kawagishi,
- E Ishimura,
- M Emoto,
- T Okamura,
- Y Okuno,
- and H Morii
Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis.
Diabetes Care November 1998 21:1848-1855; doi:10.2337/diacare.21.11.1848
- Abstract
- Full Text (PDF)
Select this article
- C J Chang,
- J S Wu,
- F H Lu,
- H L Lee,
- Y C Yang,
- and M J Wen
Fasting plasma glucose in screening for diabetes in the Taiwanese population.
Diabetes Care November 1998 21:1856-1860; doi:10.2337/diacare.21.11.1856
- Abstract
- Full Text (PDF)
Select this article
- L Niskanen,
- A Turpeinen,
- I Penttilä,
- and M I Uusitupa
Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.
Diabetes Care November 1998 21:1861-1869; doi:10.2337/diacare.21.11.1861
- Abstract
- Full Text (PDF)
Select this article
- B P Kovatchev,
- D J Cox,
- L A Gonder-Frederick,
- D Young-Hyman,
- D Schlundt,
- and W Clarke
Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.
Diabetes Care November 1998 21:1870-1875; doi:10.2337/diacare.21.11.1870
- Abstract
- Full Text (PDF)
Select this article
- M Rose,
- U Burkert,
- G Scholler,
- T Schirop,
- G Danzer,
- and B F Klapp
Determinants of the quality of life of patients with diabetes under intensified insulin therapy.
Diabetes Care November 1998 21:1876-1885; doi:10.2337/diacare.21.11.1876
- Abstract
- Full Text (PDF)
Select this article
- F J Gómez-Pérez,
- C A Aguilar-Salinas,
- J C López-Alvarenga,
- J Perez-Jauregui,
- L E Guillen-Pineda,
- and J A Rull
Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose.
Diabetes Care November 1998 21:1886-1888; doi:10.2337/diacare.21.11.1886
- Abstract
- Full Text (PDF)
Select this article
- S G Gimeno,
- S R Ferreira,
- L J Franco,
- and M Iunes
Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. The Japanese-Brazilian Diabetes Study Group.
Diabetes Care November 1998 21:1889-1892; doi:10.2337/diacare.21.11.1889
- Abstract
- Full Text (PDF)
Select this article
- R Playle,
- R L Ollerton,
- F D Dunstan,
- W D Evans,
- A Burch,
- S D Luzio,
- and D R Owens
Determining true glomerular filtration status in newly presenting type 2 diabetic subjects using age and sex adjustment.
Diabetes Care November 1998 21:1893-1896; doi:10.2337/diacare.21.11.1893
- Abstract
- Full Text (PDF)
Select this article
- R B Goldberg,
- D Einhorn,
- C P Lucas,
- M S Rendell,
- P Damsbo,
- W C Huang,
- P Strange,
- and R G Brodows
A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes.
Diabetes Care November 1998 21:1897-1903; doi:10.2337/diacare.21.11.1897
- Abstract
- Full Text (PDF)
Select this article
- P D Home,
- A Lindholm,
- B Hylleberg,
- and P Round
Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.
Diabetes Care November 1998 21:1904-1909; doi:10.2337/diacare.21.11.1904
- Abstract
- Full Text (PDF)
Select this article
- L Heinemann,
- C Weyer,
- M Rauhaus,
- S Heinrichs,
- and T Heise
Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.
Diabetes Care November 1998 21:1910-1914; doi:10.2337/diacare.21.11.1910
- Abstract
- Full Text (PDF)
Select this article
- N B Tütüncü,
- M Bayraktar,
- and K Varli
Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study.
Diabetes Care November 1998 21:1915-1918; doi:10.2337/diacare.21.11.1915
- Abstract
- Full Text (PDF)
Select this article
- J Y Poirier,
- N Le Prieur,
- L Campion,
- I Guilhem,
- H Allannic,
- and D Maugendre
Clinical and statistical evaluation of self-monitoring blood glucose meters.
Diabetes Care November 1998 21:1919-1924; doi:10.2337/diacare.21.11.1919
- Abstract
- Full Text (PDF)
Select this article
- M A Nauck,
- A Sauerwald,
- R Ritzel,
- J J Holst,
- and W Schmiegel
Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
Diabetes Care November 1998 21:1925-1931; doi:10.2337/diacare.21.11.1925
- Abstract
- Full Text (PDF)
Select this article
- C M Forsblom,
- P H Groop,
- A Ekstrand,
- K J Tötterman,
- T Sane,
- C Saloranta,
- and L Groop
Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM.
Diabetes Care November 1998 21:1932-1938; doi:10.2337/diacare.21.11.1932
- Abstract
- Full Text (PDF)
Select this article
- M T Korytkowski,
- M Mokan,
- T F Veneman,
- A Mitrakou,
- P E Cryer,
- and J E Gerich
Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness.
Diabetes Care November 1998 21:1939-1943; doi:10.2337/diacare.21.11.1939
- Abstract
- Full Text (PDF)
Select this article
- J B Redmon,
- A U Teuscher,
- and R P Robertson
Hypoglycemia after pancreas transplantation.
Diabetes Care November 1998 21:1944-1950; doi:10.2337/diacare.21.11.1944
- Abstract
- Full Text (PDF)
Select this article
- V Sánchez-Margalet,
- J A Lobón,
- A González,
- M L Fernández-Soto,
- F Escobar-Jiménez,
- and R Goberna
Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels.
Diabetes Care November 1998 21:1951-1954; doi:10.2337/diacare.21.11.1951
- Abstract
- Full Text (PDF)
Select this article
- J E Shaw,
- C H van Schie,
- A L Carrington,
- C A Abbott,
- and A J Boulton
An analysis of dynamic forces transmitted through the foot in diabetic neuropathy.
Diabetes Care November 1998 21:1955-1959; doi:10.2337/diacare.21.11.1955
- Abstract
- Full Text (PDF)
Select this article
- C Meyer,
- R Grossmann,
- A Mitrakou,
- R Mahler,
- T Veneman,
- J Gerich,
- and R G Bretzel
Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients.
Diabetes Care November 1998 21:1960-1966; doi:10.2337/diacare.21.11.1960
- Abstract
- Full Text (PDF)
Select this article
- M A Charles,
- P Morange,
- E Eschwège,
- P André,
- P Vague,
- and I Juhan-Vague
Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.
Diabetes Care November 1998 21:1967-1972; doi:10.2337/diacare.21.11.1967
- Abstract
- Full Text (PDF)
Select this article
- D Fedele,
- C Coscelli,
- F Santeusanio,
- A Bortolotti,
- L Chatenoud,
- E Colli,
- M Landoni,
- and F Parazzini
Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.
Diabetes Care November 1998 21:1973-1977; doi:10.2337/diacare.21.11.1973
- Abstract
- Full Text (PDF)
Select this article
- L Jovanovic,
- B E Metzger,
- R H Knopp,
- M R conley,
- E Park,
- Y J Lee,
- J L Simpson,
- L Holmes,
- J H Aarons,
- and J L Mills
The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development.
Diabetes Care November 1998 21:1978-1984; doi:10.2337/diacare.21.11.1978
- Abstract
- Full Text (PDF)
Select this article
- K A Fraser-Reynolds,
- J D Butzner,
- D K Stephure,
- R A Trussell,
- and R B Scott
Use of immunoglobulin A-antiendomysial antibody to screen for celiac disease in North American children with type 1 diabetes.
Diabetes Care November 1998 21:1985-1989; doi:10.2337/diacare.21.11.1985
- Abstract
Select this article
- T A Elhadd,
- F Khan,
- G Kirk,
- M McLaren,
- R W Newton,
- S A Greene,
- and J J Belch
Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes.
Diabetes Care November 1998 21:1990-1996; doi:10.2337/diacare.21.11.1990
- Abstract
- Full Text (PDF)
Select this article
- T J Berg,
- J T Clausen,
- P A Torjesen,
- K Dahl-Jørgensen,
- H J Bangstad,
- and K F Hanssen
The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.
Diabetes Care November 1998 21:1997-2002; doi:10.2337/diacare.21.11.1997
- Abstract
- Full Text (PDF)
Select this article
- L Lobefalo,
- A Verrotti,
- L Mastropasqua,
- G Della Loggia,
- V Cherubini,
- G Morgese,
- P E Gallenga,
- and F Chiarelli
Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy.
Diabetes Care November 1998 21:2003-2006; doi:10.2337/diacare.21.11.2003
- Abstract
- Full Text (PDF)
Select this article
- K Rossing,
- P Jacobsen,
- P Rossing,
- E Lauritzen,
- H Lund-Andersen,
- and H H Parving
Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy.
Diabetes Care November 1998 21:2007-2015; doi:10.2337/diacare.21.11.2007
- Abstract
- Full Text (PDF)
Select this article
- K Kashiwazaki,
- T Hirano,
- G Yoshino,
- M Kurokawa,
- H Tajima,
- and M Adachi
Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria.
Diabetes Care November 1998 21:2016-2020; doi:10.2337/diacare.21.11.2016
- Abstract
- Full Text (PDF)
- R Lorenz
The problem with intensive therapy.
Diabetes Care November 1998 21:2021-2022; doi:10.2337/diacare.21.11.2021
- Full Text (PDF)
- D S Bell and
- F Ovalle
Metformin lowers lipoprotein(a) levels.
Diabetes Care November 1998 21:2028; doi:10.2337/diacare.21.11.2028b
- Full Text (PDF)
- D S Bell and
- F Ovalle
Troglitazone interferes with gemfibrozil's lipid-lowering action.
Diabetes Care November 1998 21:2028-2029; doi:10.2337/diacare.21.11.2028a
- Full Text (PDF)
- R J Andrade,
- M Lucena,
- J L Vega,
- M Torres,
- F J Salmerón,
- V Bellot,
- M D García-Escaño,
- and P Moreno
Acarbose-associated hepatotoxicity.
Diabetes Care November 1998 21:2029-2030; doi:10.2337/diacare.21.11.2029
- Full Text (PDF)
- K Y Mumcuoglu,
- A Ingber,
- L Gilead,
- J Stessman,
- R Friedmann,
- H Schulman,
- H Bichucher,
- I Ioffe-Uspensky,
- J Miller,
- R Galun,
- and I Raz
Maggot therapy for the treatment of diabetic foot ulcers.
Diabetes Care November 1998 21:2030-2031; doi:10.2337/diacare.21.11.2030
- Full Text (PDF)
- N Eibl,
- C Schnack,
- and G Schernthaner
Magnesium supplementation in type 2 diabetes.
Diabetes Care November 1998 21:2031-2032; doi:10.2337/diacare.21.11.2031
- Full Text (PDF)
- G T Ko,
- J C Chan,
- and C S Cockram
Supplement to the use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of having diabetes.
Diabetes Care November 1998 21:2032-2033; doi:10.2337/diacare.21.11.2032
- Full Text (PDF)
- A R Uysal,
- M F Erdoğan,
- G Sahin,
- N Kamel,
- and G Erdoğan
Clinical and metabolic effects of fasting in 41 type 2 diabetic patients during Ramadan.
Diabetes Care November 1998 21:2033-2034; doi:10.2337/diacare.21.11.2033
- Full Text (PDF)
- K Kameoka,
- H Isotani,
- K Tanaka,
- H Kitaoka,
- and N Ohsawa
Impaired insulin secretion in Japanese diabetic subjects with an A-to-G mutation at nucleotide 8296 of the mitochondrial DNA in tRNA(Lys)
Diabetes Care November 1998 21:2034-2035; doi:10.2337/diacare.21.11.2034
- Full Text (PDF)
- J D Lalau,
- C Mourlhon,
- A Bergeret,
- and C Lacroix
Consequences of metformin intoxication.
Diabetes Care November 1998 21:2036-2037; doi:10.2337/diacare.21.11.2036
- Full Text (PDF)
- J Morimoto,
- T Maruyama,
- A Kasuga,
- Y Ozawa,
- A Kobayashi,
- S Funakoshi,
- R Iwasaki,
- Y Suzuki,
- A Shimada,
- and T Saruta
Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
Diabetes Care November 1998 21:2037-2039; doi:10.2337/diacare.21.11.2037
- Full Text (PDF)
- F Pouwer,
- F J Snoek,
- and R J Heine
Ceiling effect reduces the validity of the Diabetes Treatment Satisfaction Questionnaire.
Diabetes Care November 1998 21:2039; doi:10.2337/diacare.21.11.2039b
- Full Text (PDF)
- G Steiner
Micronized fenofibrate in the management of dyslipidemia.
Diabetes Care November 1998 21:2039-2040; doi:10.2337/diacare.21.11.2039a
- Full Text (PDF)
- E Raynaud,
- J F Brun,
- A Perez-Martin,
- and J Mercier
Association between fibrinogen levels and insulin resistance.
Diabetes Care November 1998 21:2040-2041; doi:10.2337/diacare.21.11.2040
- Full Text (PDF)
- V Lassmann-Vague,
- M SanMarco,
- P J LeJeune,
- C Alessis,
- P Vague,
- and P Belicar
Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.
Diabetes Care November 1998 21:2041-2044; doi:10.2337/diacare.21.11.2041
- Full Text (PDF)

Current Issue

February 2012, 35 (2)

Print ISSN: 0149-5992
Online ISSN: 1935-5548

Diabetes Care

Gestational diabetes mellitus: who to test. How to test.

Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.

Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test.

Gestational diabetes: do lean young caucasian women need to be tested?

The 75-g glucose tolerance test in pregnancy: a reference range determined on a low-risk population and related to selected pregnancy outcomes.

Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study.

Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India.

Islet cell autoimmunity in white and black children and adolescents with IDDM.

Differential effects of BMI on diabetes risk among black and white Americans.

Association of waist circumference with risk of hypertension and type 2 diabetes in Nigerians, Jamaicans, and African-Americans.

Plasma homocysteine concentrations in patients with type 1 diabetes.

Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis.

Fasting plasma glucose in screening for diabetes in the Taiwanese population.

Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.

Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.

Determinants of the quality of life of patients with diabetes under intensified insulin therapy.

Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose.

Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. The Japanese-Brazilian Diabetes Study Group.

Determining true glomerular filtration status in newly presenting type 2 diabetic subjects using age and sex adjustment.

A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes.

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.

Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study.

Clinical and statistical evaluation of self-monitoring blood glucose meters.

Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.

Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM.

Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness.

Hypoglycemia after pancreas transplantation.

Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels.

An analysis of dynamic forces transmitted through the foot in diabetic neuropathy.

Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients.

Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.

Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.

The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development.

Use of immunoglobulin A-antiendomysial antibody to screen for celiac disease in North American children with type 1 diabetes.

Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes.

The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes.

Blue-on-yellow and achromatic perimetry in diabetic children without retinopathy.

Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy.

Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria.

The problem with intensive therapy.

Metformin lowers lipoprotein(a) levels.

Troglitazone interferes with gemfibrozil's lipid-lowering action.

Acarbose-associated hepatotoxicity.

Maggot therapy for the treatment of diabetic foot ulcers.

Magnesium supplementation in type 2 diabetes.

Supplement to the use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of having diabetes.

Clinical and metabolic effects of fasting in 41 type 2 diabetic patients during Ramadan.

Impaired insulin secretion in Japanese diabetic subjects with an A-to-G mutation at nucleotide 8296 of the mitochondrial DNA in tRNA(Lys)

Consequences of metformin intoxication.

Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.

Ceiling effect reduces the validity of the Diabetes Treatment Satisfaction Questionnaire.

Micronized fenofibrate in the management of dyslipidemia.

Association between fibrinogen levels and insulin resistance.

Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.

This Issue

Current Issue

From the Cover